Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Tissue Extracts”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 865 records · Page 48Linked to original sources
PubMed2004

A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentation.

Apoptotic markers consist of either caspase substrate cleavage products or phenotypic changes that manifest themselves as a consequence of caspase-mediated substrate cleavage. We have shown recently that pharmacological inhibitors of caspase activity prevent the appearance of two such apoptotic manifestations, alphaII-spectrin cleavage and DNA fragmentation, but that blockade of the latter required a significantly higher concentration of inhibitor. We investigated this phenomenon through the use of a novel radiolabeled caspase inhibitor, [(125)I]M808, which acts as a caspase active site probe. [(125)I]M808 bound to active caspases irreversibly and with high sensitivity in apoptotic cell extracts, in tissue extracts from several commonly used animal models of cellular injury, and in living cells. Moreover, [(125)I]M808 detected active caspases in septic mice when injected intravenously. Using this caspase probe, an active site occupancy assay was developed and used to measure the fractional inhibition required to block apoptosis-induced DNA fragmentation. In thymocytes, occupancy of up to 40% of caspase active sites had no effect on DNA fragmentation, whereas inhibition of half of the DNA cleaving activity required between 65 and 75% of active site occupancy. These results suggest that a high and persistent fractional inhibition will be required for successful caspase inhibition-based therapies.

Amino Acid Chloromethyl Ketones↗
PubMed1992

Immunological characterization of oviductal glycoproteins associated with the zona pellucida of the golden hamster egg.

Three monoclonal antibodies (MAbs) were produced against materials obtained from the golden hamster oviduct. The MAbs (C11E8, C8B11, and A3D5) selectively reacted with the zona pellucida (ZP) of oviductal eggs. An immunohistochemical study demonstrated that all MAbs bound strongly to the epithelial cells of the oviduct and, to a lesser extent, of the uterus, the cervix, and the vagina. Weak reactions were also observed with some other tissues. All immunohistochemical reactions were completely eliminated by treatment of tissues with periodic acid, suggesting that the antigenic determinants that react with the MAbs are carbohydrate in nature. Antigens that reacted with the MAbs were characterized by immunoblotting analyses of 1- or 2-dimensional polyacrylamide gels after electrophoresis to fractionate tissue extracts under reducing conditions. With the oviductal extract, C11E8 and A3D5 specifically bound to broad bands that corresponded to macromolecules of more than 200 and 160 kD, respectively, whereas C8B11 reacted with a broad range of macromolecules, with the strongest reactivity being detected at molecular weights (MWs) higher than 160 kD. The macromolecules that reacted with the MAbs had carbamilation trains, suggestive of extensive microheterogeneity with respect to charge and size. Similar substances of high MW were not detected in extracts of tissues from the other reproductive organs. In addition, one MAb-positive oviductal antigen bound to the ZP of ovarian eggs, but the others did not bind to the ZP of ovarian eggs. This result indicates that the binding activity is specific for the oviductal glycoproteins. We have thus established clones that produce 3 different MAbs with strong affinity for oviduct-specific glycoproteins, one of which is associated with the ZP of the golden hamster.

Animals↗
PubMed1983

Occurrence of both urokinase and tissue plasminogen activator in the human endometrium.

The presence of two different plasminogen activators, urokinase and tissue activator, in the endometrium was demonstrated immunologically. Tissue activator was prevalent and urokinase was present in only minor amounts in endometrial tissue extractions. In tissue culture, on the contrary, endometrial explants released more urokinase than tissue activator into the medium and the fibrinolytic activity of the medium was mainly due to urokinase. This may reflect different modes of intracellular storage of the two activators, or the presence of a pre-urokinase which is immunologically different from urokinase and which is activated upon release. The amount of urokinase and fibrinolytic activity released into the culture medium was higher when endometrium samples had been obtained in the midcycle phase than in the proliferative and luteal phases. This pattern mimics the in vivo release of plasminogen activator from the endometrium into the uterine fluid. Endometrium obtained from IUD-users had a higher content of urokinase than that obtained from non-users.

Culture Media↗
PubMed1993

Real and imagined clinicopathological limits of "prion dementia".

The term "prion dementia" has been proposed to replace "spongiform encephalopathy", to accommodate the existence of atypical forms of these "prion protein" (PrP) cerebral amyloidoses that may not show spongiform changes in the brain. We tested brain tissue extracts for the presence of PrP from 46 cases (including 13 familial cases) of non-spongiform dementias with a variety of associated neurological signs, referred to our laboratory for primate transmission studies. None of the cases transmitted disease to primates, and none had PrP detectable by western immunoblots of extracted brain tissue. We conclude that prion dementias are not lurking undetected within the larger landscape of neurodegenerative disorders, and that their clinicopathological limits are, except for a small number of previously reported familial cases, essentially those of spongiform encephalopathy.

Adult↗
PubMedDate not supplied

Identification of immunoreactive somatostatin in the rat harderian gland: regulation of its content by growth hormone, beta-adrenergic agonists and calcium channel blockers.

Immunoreactive somatostatin (IRS) was identified in the male rat Harderian gland (HG) by radioimmunoassay. Tissue was extracted and a displacement curve performed; there were no significant differences between values obtained with serial dilutions of extracted tissue and those from purified somatostatin standard used in the radioimmunoassay. Basal values of HG-IRS were found to be in the nanomolar range (10.8 +/- 3.5 ng IRS/mg protein). Hypophysectomy did not change the HG-IRS but, in vivo growth hormone (GH) treatment led to a dramatic increase (6-7-fold) in the levels of IRS in the HG. Isoproterenol, a beta-adrenergic agonist, when administered in vivo significantly decreased the HG-IRS content. The effect of two different calcium channel blockers on the isoproterenol-induced decrease of HG-IRS was studied; no changes were observed with nifedipine but verapamil, injected one hour after isoproterenol administration, prevented the drop in HG-IRS levels. These data demonstrate the existence of IRS in a new location, the rat Harderian gland, and support a classical endocrine regulation for its tissue concentration.

Animals↗
PubMed2003

Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.

OBJECTIVES: To characterize the immunohistochemical staining (IHS) of precursor forms of prostate-specific antigen (pro-PSA) forms in prostate cancer, high-grade prostatic intraepithelial neoplasia (HGPIN), and benign tissue from the peripheral and transition zones. Pro-PSA have previously been shown to be more concentrated in prostate cancer tissue extracts than in benign tissue. METHODS: Prostate needle biopsies showing HGPIN (22 sections, 11 patients) and adenocarcinoma (30 sections, 21 patients) and 17 radical prostatectomy and 3 open prostatectomy specimens were identified from the surgical pathology files of Johns Hopkins Hospital. IHS was performed on formalin-fixed, paraffin-embedded sections using one monoclonal antibody (mAB) against pro-PSA with a truncated pro-leader peptide containing two amino acids, [-2]pPSA, and a second mAB against native pro-PSA ([-5/-7]pPSA). RESULTS: The mABs were specific for both benign and malignant prostatic glandular tissue and did not stain stromal, vascular, or colonic tissue when present in the specimens. All sections with HGPIN and/or adenocarcinoma showed staining with both mABs. HGPIN was strongly positive in most cases (66.1%). The native pro-PSA mAB showed little differential between cancer and benign glands, and the mAB to the truncated [-2]pPSA stained cancer tissue more strongly than benign tissue. Benign atrophic glands often showed negative or weak/patchy staining. No difference was found in the staining pattern between benign glands in the peripheral zone and transition zone. CONCLUSIONS: This study is the first to demonstrate that mABs to pro-PSA can be used as specific IHS for benign and malignant prostatic tissue. [-2]pPSA appears to be preferentially more concentrated in cancer tissue than in benign glands, correlating with previous tissue extract studies. Unlike previous studies with PSA staining, the IHS for pro-PSA remained uniform among the different tumor grades. Therefore, pro-PSA may be a useful marker in differentiating high-grade prostate adenocarcinoma from other non-prostate carcinomas.

Adenocarcinoma↗
PubMed1999

Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma.

Although fibrinolysis has been implicated in the progression and metastasis of lung cancer, no detailed study has been carried out on components measured in samples from both plasma and tumour. This study thus provides the first comprehensive data obtained from 166 patients diagnosed with non-small cell lung carcinoma. Plasma samples were obtained at diagnosis and tumour samples during surgical resection. Appropriate control samples were obtained from normal subjects and patients with chronic obstructive airways disease (plasma) and from organ donors (normal lung tissue). Assays were performed on plasma and tissue extracts for tissue plasminogen activator, urokinase-like activator and plasminogen activator inhibitor (activity and antigen in all cases), together with plasmin-antiplasmin complex, soluble fibrin, D-dimer and thrombin-antithrombin complex. Levels of D-dimer, thrombin-antithrombin complex and plasmin-antiplasmin complex were all significantly higher in plasma from patients, whereas urokinase-like activator activity was reduced. Only two parameters were significantly altered in both the core and periphery of tumour tissue: levels of D-dimer were increased and tissue-type plasminogen activator activity was reduced. Interestingly, significant differences in levels of other fibrinolytic parameters were detected in the core and periphery of tumours. Significant activation of fibrinolysis was indicated in patients, although the origin of this could not be related consistently to changes in levels of plasminogen activator and inhibitor.

Adult↗
PubMed1970

Growth Regulator Changes in Cotton Associated with Defoliation Caused by Verticillium albo-atrum.

Cotton plants, variety Acala 4-42 family 77 (Gossypium hirsutum L.,), were stem puncture-inoculated with either a defoliating isolate (T9) or a nondefoliating isolate (SS4) of Verticillium albo-atrum (Reinke and Berth.). As symptoms developed, growth regulators were assayed in diseased plants to discern their importance in the disease syndrome.An Avena coleoptile straight growth bioassay demonstrated the presence of several growth-regulatory compounds in cotton tissue extracts. Indoleacetic acid was among the compounds whose effects on coleoptile growth were influenced by disease development. Coleoptile growth due to indoleacetic acid was greater in extracts of diseased stems and leaves than in extracts of comparable healthy tissues. During the defoliation period the T9 and SS4 isolates appeared equally effective in increasing indoleacetic acid and reducing indoleacetic acid decarboxylation. Preceding defoliation, however, in plants showing equivalent symptoms the degradation of auxin was reduced more by infection with T9, the defoliating isolate. The reduced auxin degradation appeared to be releated to concomitant increases in caffeic acid and other indoleacetic acid-oxidase inhibitors in the affected tissues.Abscisic acid in tissue extracts strongly inhibited coleoptile growth. During the defoliation period gas-liquid chromatographic and ultraviolet absorption measurements revealed that abscisic acid levels were approximately doubled in T9-infected leaves but were relatively unaffected in leaves infected with the nondefoliating isolate and in stems infected with either isolate.The onset of epinasty and especially defoliation was also accompanied by increased ethylene production in diseased plants. Ethylene in gas samples taken from jars confining plants infected with SS4 or T9, respectively, was increased 2- and 5-fold over uninoculated controls. Ethylene supplied exogenously to healthy plants in concentrations as low as 0.2 microliter per liter induced both the epinasty and defoliation symptoms characteristic of Verticillium infection. Ethylene treatment did not, however, induce other symptoms of Verticillium infection and did not affect endogenous levels of abscisic acid.Defoliation of T9-but not SS4-infected plants apparently is related to the differential alterations in abscisic acid and ethylene levels induced by each isolate, and perhaps to differential alterations in initial rates of indoleacetic acid decarboxylation. These growth regulator alterations apparently are reflections of altered host metabolism rather than direct contributions of the invading fungus.

Journal Article↗
PubMed2003

Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults.

BACKGROUND: Linear IgA disease (LAD; adult and childhood) is a dapsone-responsive, acquired immunobullous disorder mediated by IgA antibodies directed at target antigens within the epithelial basement membrane. These antigens have not been completely characterized. OBJECTIVES: To identify the target antigens in LAD, and to correlate these with the antibody isotype. METHODS: We used 101 LAD sera without IgG antibodies detected by indirect immunofluorescence. The sera were analysed by immunoblotting for IgA (65 adults and 36 children) and IgG (61 adults and 34 children) autoantibodies, on salt-split, urea-extracted epidermal tissue extracts. RESULTS: Antigens were targeted in LAD by IgA antibodies (54 adults and 23 children), IgG antibodies (34 adults and 19 children), and both isotypes (30 adults and 16 children). Three major antigens were recognized by IgA antibodies: LAD285 (22 adults and three children), BP230 (30 adults and eight children) and BP180 (collagen XVII), including the 97-kDa ectodomain (52 adults and 20 children). Seven 'minor' antigens were occasionally detected (18 adults and 13 children). IgA antibodies bound multiple antigens (33 adults and nine children) more frequently than single antigens (21 adults and 14 children), but the binding to multiple antigens was more restricted in children than in adults. IgG antibodies mainly bound a single antigen (29 adults and 16 children), predominantly BP180. CONCLUSIONS: There was variation in the autoantibody response within the disease and the patient, with regard to target molecules and autoantibody class. The finding that IgG as well as IgA autoantibodies predominantly target BP180 supports a pivotal role for collagen XVII in adult and childhood LAD. The IgG response was very restricted compared with IgA autoantibodies (P < 0.01). Autoantibodies from children had a more restricted antigen repertoire than from adults (P < 0.05). Epitope spreading is common in LAD and is affected by the class of autoantibody and age of the patient.

Adolescent↗
PubMed1993

Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy.

Paracrine interactions between fibroblasts residing in the retro-ocular space and infiltrating lymphocytes/macrophages are thought to be of central importance in the pathogenesis of Graves' ophthalmopathy (GO). Although various roles have been suggested for interferon-gamma (IFN gamma), tumour necrosis factor-alpha (TNF alpha) and interleukin-1 alpha (IL-1 alpha) in GO, their actual presence in Graves' retro-ocular connective tissue has not been demonstrated. We examined surgical specimens obtained during orbital decompression from patients with severe GO (n = 6), and from normal individuals (n = 5), for the presence of IFN gamma, TNF alpha and IL-1 alpha. We used immunohistochemical methods on frozen tissue sections and primary fibroblast cultures, and sodium dodecylsulfate polyacrylamide-gel electrophoresis of tissue extracts and tissue culture supernatants. In addition, immunohistochemical staining of tissues for characterization of the mononuclear cell infiltrates was performed. Aggregates of mononuclear cells in retro-ocular connective and fatty tissue were found in five of six GO tissue specimens, but in none of the control specimens. We detected immunoreactivity for the three cytokines (IFN gamma, TNF alpha and IL-1 alpha) in the five GO tissue specimens that contained mononuclear cell aggregates. In addition, IL-1 alpha immunoreactivity was demonstrable in primary and subsequent GO fibroblast cultures and in their supernatants. In contrast, no immunoreactivity for any of these cytokines was detected in tissue specimens, primary cultures or culture supernatants derived from normal individuals. The presence of mononuclear cell infiltrates and associated immunoreactivity for IFN gamma, TNF alpha, IL-1 alpha in retro-ocular connective tissue derived from patients with GO suggests that the previously demonstrated in vitro functions of these cytokines may indeed be operative in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

Connective Tissue↗
PubMed2001

The oral anticoagulant saga: past, present, and future.

Oral anticoagulation originated with the discovery of the harmful agent causing "sweet clover disease" in cattle in North America in the 1920s. The causative agent dicoumarol was isolated in Link's laboratory in 1940. A range of related compounds was then synthesized, the most popular of which proved to be warfarin. Oral anticoagulant administration posed problems of individual variation in response to these drugs and the need for regular laboratory monitoring by prothrombin time (PT). Monitoring problems arose from the introduction in the 1950s of some poorly responsive commercial tissue extracts for use as tissue extract thromboplastin reagent in the PT. More oral anticoagulant drug was then needed to prolong the test to the required therapeutic targets, with a resultant increase in bleeding. It was not until 1983 that the problem was resolved and it was shown that the less intense UK-type regimen was just as effective as the higher North American type dosage in the prevention of venous thrombosis but caused much less bleeding. This study led to the widespread adoption of the "low-dose warfarin" regimen that, combined with the World Health Organization PT standardization scheme using the international normalized ratio (INR), has led to improved effectiveness and safety of oral anticoagulation. This has permitted increased administration of warfarin in a widening spectrum of clinical disorders. The last remaining problem is the limited success of doctors in achieving the therapeutic INR targets, which may be improved by computer-assisted dosage.

Administration, Oral↗
PubMed1976

Blood fibrinolytic activity and fibrinoid necrosis of small arteries in the rats treated with renal cortical extract.

In order to determine the role of fibrinolytic system in the production of fibrinoid necrosis, blood fibrinolytic activities were measured in the rats nephrectomized and administered with the subcellular fractions (lysosomal or microsomal fraction) of the rat kidney cortical extract. Tissue plasminogen activator was present in both fractions and blood fibrinolytic activity was increased in the rats so treated. But fibrinoid necrosis in pancreatic and mesenteric small arteries was observed only in those administered lysosomal fraction. Direct relationship between the increase of blood fibrinolytic activity and the aggravation of the vascular degeneration could not be observed in this experiment.

Animals↗
PubMed2004

Selectivity of effects of redox-active cobalt(III) complexes on tumor tissue.

AIM: To estimate the selectivity of action of cobalt complexes on tumor tissue. MATERIALS AND METHODS: Cobalt(III) complexes containing both the tetradentate Schiff-base ligand derived from acetylacetone and ethylenediamine, and compounds of the vitamin PP series or their synthetic analogs, viz. nicotinamide, isonicotinamide or nicotinic acid, as extra (axial) ligands, were tested in vivo on transplanted mice tumors, namely Lewis lung carcinoma (3LL), melanoma B16, and mammary adenocarcinoma Ca755. concentrations of malondialdehyde in tissue extracts were measured by standard biochemical methods. The rate of DNA unwinding was used to detect DNA damage in tumor cells. Level of tumor hypoxia as well as bioenergetic status were estimated using 31P NMR spectroscopy in perchloric acid extracts of tissue. RESULTS: A significant and selective increase of malondialdehyde in tumor tissue reflecting activation of lipid peroxidation was found after administration of the complexes. The bioenergetic status in tumor was also selectively affected by the complexes: minimization of signals of high-energy phosphates was observed two hours after injection of the complexes. An increase of the number of DNA single-strand breaks was registered in tumor tissue, supporting the suggestion that the complexes may directly affect DNA. A correlation between the above tumor effects and the structure of axial ligands was demonstrated. CONCLUSION: Cobalt(III) complexes affect tumor tissue with a very high level of selectivity; in particular they activate lipid peroxidation, induce DNA single-strand breaks, suppress the bioenergetic status, and enhance hypoxia. It is supposed that the selective action of these complexes on tumor tissue is due to peculiarities of tumor microphysiology, in particular significant tumor hypoxia.

Adenocarcinoma↗
PubMed1986

Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay.

TSP-180 is a Mr 180,000 cell surface protein found on several murine lung carcinomas but not on fibroblast or sarcoma cell lines. Monoclonal antibody 135-13C binds to TSP-180 with high affinity but could not be used to quantitate the protein in tumors and normal tissue (Cancer Res., 41: 3465-3470, 1981). TSP-180 was purified from a transplantable BALB/c carcinoma (line 1 cells) by immunoaffinity chromatography and used as an immunogen to produce another monoclonal antibody (346-11A) to a different epitope on the molecule. A two-site solid-phase radioimmunoassay for TSP-180 was developed to quantitate TSP-180 in tissue extracts. The assay can detect as little as 3 ng of TSP-180 in samples up to 10 mg of protein. Analyses of several lung carcinoma cell lines confirmed that TSP-180 is present in all (five of five) cell lines ranging from 40 to 800 ng per mg of cell protein extract. Mouse tissues from normal and tumor-bearing mice were analyzed for TSP-180. Values for line 1 tumors growing i.m. were about 70 ng of TSP-180 per mg of protein. Normal tissue from normal and tumor-bearing mice contained low levels of TSP-180 from less than 0.3 ng/mg of protein for liver to a high of about 11 ng/mg of protein for leg muscle. Finally, small benign urethane-induced adenomas (1 to 2 mm) from BALB/c mice had moderate amounts of TSP-180 (11 ng/mg of protein), while two primary lung adenocarcinomas in the same animals had 20 and 47 ng/mg of protein, respectively, suggesting that TSP-180 expression may increase with increasing cancer of these tumors. Analyses of individual urethane-induced lung tumors from A/J mice showed that 11 of 13 carcinomas had high levels of TSP-180, while only 1 of 6 adenomas had a detectable amount of TSP-180, and that was at a moderate level. Specific quantitation of tumor markers in normal, benign, and malignant lung tissue may be helpful in identifying different levels of gene expression as tumors progress to more malignant states.

Adenoma↗
PubMed1983

[Vascular perfusion of an intestinal segment in the catfish (Ictalurus melas, R): demonstration of the vasoactive effects of mammalian VIP and of gastrointestinal extracts from teleost fish].

Through the middle mesenteric artery and the hepatic portal vein it is possible to perfuse specifically a small part of the catfish midgut. Using a tested VIP extraction procedure it is shown that trout and catfish extracts of oesophagus, stomach, midgut and hindgut induce a vasodilation similar to that of porcine VIP. The importance of the vasodilatory response depends on the level of perfused VIP and extracted tissue.

Animals↗
PubMed1981

Immunological characterization of plasminogen activator activities in human tissues and body fluids.

Human plasminogen activators were compared immunologically in both a double-diffusion technique and quenching experiments on the fibrinolytic activities of the activators. Antisera against HMW and LMW urokinase and an antiserum against highly purified tissue plasminogen activator from human uterus were used. It was found that uterine tissue plasminogen activator and urokinase are two immunologically distinct plasminogen activators. The occurrence of the two kinds of plasminogen activators in human tissues and body fluids was studied on the basis of the quenching of the activities by antibodies. In tissue extracts, mainly tissue plasminogen activator was found. Seminal plasma exhibited a high plasminogen activator activity, consisting of both urokinase and tissue plasminogen activator-related activators. Urine contained a small amount of tissue plasminogen activator-related activator in addition to urokinase. The low plasminogen activator activities of saliva and tears were completely attributed to activators related to tissue plasminogen activator.

Animals↗
PubMed1993

Ovalbumin-like immunoreactivity detected in chicken sensory neurons by antibodies to aldehyde-treated ovalbumin.

A method has been developed to raise an antiserum against ovalbumin that can detect this antigen immunohistochemically in chicken sensory ganglia. Ovalbumin-like immunoreactivity has been identified in a subpopulation of chicken dorsal root ganglion neurons by the generation of antibodies to aldehyde-conjugated ovalbumin but not by the antibodies to native ovalbumin, although both antibodies recognize the much higher concentrations of ovalbumin in sections of the oviduct. Biochemical analysis demonstrated that the antigen is more readily detectable in fixed tissue extracts than in fresh tissue extracts. Sensitive immunoblot analysis combined with affinity purification of the antigen, has confirmed that the antigen is of the same molecular weight as ovalbumin. Furthermore, the immunoreactive material elutes at a position identical to native ovalbumin on a molecular sieve column. These findings argue that molecules sensitive to aldehyde fixation may be more readily detected by the use of antisera prepared against aldehyde-modified antigens. The function of the ovalbumin-like antigen in these neurons is unknown.

Animals↗